Molnupiravir, also known by its brand name Lagevrio, represents a significant advancement in the battle against COVID-19. This oral antiviral medicine works by introducing errors into the SARS-CoV-2's genetic sequence, https://ezekielnohz212282.wikipresses.com/7240105/molnupiravir_a_sars_cov_2_treatment_option